• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT COBE SPECTRA BLOOD COLLECTION; COBE SPECTRA WHITE BLOOD CELL SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT COBE SPECTRA BLOOD COLLECTION; COBE SPECTRA WHITE BLOOD CELL SET Back to Search Results
Catalog Number 777006000
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Low Blood Pressure/ Hypotension (1914); Dizziness (2194); Diaphoresis (2452)
Event Date 06/20/2016
Event Type  Injury  
Manufacturer Narrative
Investigation: per the american association of blood banks (aabb) therapeutic apheresis: a physician's handbook,t he rate of adverse events during therapeutic apheresis is 4-5% with the risk being slightly higher during a first-time procedure.Within the study, most complications were minor and well tolerated.A review of the device history record for this lot showed no irregularities during manufacturing that were relevant to this issue.Terumo bct performed an autotest and full simulated run on the machine involved in this event.No issues were found.Root cause: the available evidence points to the reactions as being vasovagal and physiologic responses to the apheresis procedures.
 
Event Description
The customer reported that a patient had a reaction during a mononuclear cell (mnc) collection during an mnc research procedure.The patient became diaphoretic and hypotensive after the first attempt to place peripheral iv.This was the patient's first donation procedure.This initial reaction was resolved.One hour and ten minutes after the start of the procedure, the patient complained of dizziness and was hypotensive.One liter of normal saline was administered as a bolus.The customer suspects vasovagal reaction.The procedure was ended when adequate access was lost at 5,200ml and the procedure was not restarted.The patient was discharged on the same day as his values returned to his healthy baseline.The disposable set is not available for return, because it was discarded by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBE SPECTRA BLOOD COLLECTION
Type of Device
COBE SPECTRA WHITE BLOOD CELL SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
matthew bickford
10810 w collins ave
lakewood, CO 80215
3032052494
MDR Report Key5816918
MDR Text Key50292478
Report Number1722028-2016-00425
Device Sequence Number1
Product Code GKT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BK020041
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Health Professional
Type of Report Initial
Report Date 07/22/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/22/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/01/2018
Device Catalogue Number777006000
Device Lot Number02Z15207
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/29/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/18/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age00039 YR
Patient Weight116
-
-